BGH: Reichweite und Grenzen der Kausalitätsvermutung des § 84 II AMG
Discussion of the judgement of the Federal Court of Justice (BGH, 26.03.2013 – VI ZR 109/12) regarding liability for medicinal products according to Section 84 German Drug Act
Please find below some recent news of relevance for the life sciences sector as well as press releases and publications published by us.
Discussion of the judgement of the Federal Court of Justice (BGH, 26.03.2013 – VI ZR 109/12) regarding liability for medicinal products according to Section 84 German Drug Act